Raia Drogasil (RADLY) Stock Price, News & Analysis

Company Overview

Raia Drogasil S.A., known as RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a nationwide network of drugstores under the Raia and Drogasil brands, offering prescription medicines, over-the-counter products, vitamins, personal-care items, cosmetics and other health-related merchandise.

The company also provides digital shopping and delivery services through its online channels, supporting customers with prescription fulfillment and access to pharmacy products. Its stores and digital operations primarily serve consumers throughout Brazil, with a focus on combining retail pharmacy services with broader healthcare offerings.

Raia Drogasil was created in 2011 through the merger of Drogasil and Droga Raia, two established Brazilian pharmacy chains. The company later adopted the RD Saúde name to reflect its broader healthcare strategy, while continuing to operate its established pharmacy brands.

Key Stats

• Today's Range: $3.28 to $3.50
• 50-Day Range: $3.25 to $4.00
• 52-Week Range: $3.08 to $5.34
• Volume: 60,116 shs
• Average Volume: 141,854 shs
• Market Capitalization: $4.37 billion
• P/E Ratio: 66.40
• Dividend Yield: 1.20%
• Price Target: N/A
• Consensus Rating: Hold

Raia Drogasil Stock Analysis - MarketRank™

Raia Drogasil scored higher than 46% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Hold

Consensus Rating

Raia Drogasil has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Raia Drogasil has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 41.18%

Earnings Growth

Earnings for Raia Drogasil are expected to grow by 41.18% in the coming year, from $0.17 to $0.24 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Raia Drogasil is 66.40, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.77.

Price to Earnings Ratio vs. Sector

The P/E ratio of Raia Drogasil is 66.40, which means that it is trading at a more expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 13.84.

Price to Book Value per Share Ratio

Raia Drogasil has a P/B Ratio of 3.32. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the float of Raia Drogasil has been sold short.

Short Interest Ratio / Days to Cover

Raia Drogasil has a short interest ratio ("days to cover") of 0.01, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Raia Drogasil has recently decreased by 42.82%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Raia Drogasil pays a meaningful dividend of 1.03%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Raia Drogasil does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Raia Drogasil is 80.00%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on earnings estimates, Raia Drogasil will have a dividend payout ratio of 16.67% next year. This indicates that Raia Drogasil will be able to sustain or increase its dividend.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.45

News Sentiment

Raia Drogasil has a news sentiment score of 0.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Consumer Staples companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for Raia Drogasil this week, compared to 0 articles on an average week.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Raia Drogasil insiders have not sold or bought any company stock.

Percentage Held by Institutions

Raia Drogasil has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/04/2026
• Today: 9/30/2026
• Next Earnings (Estimated): 11/03/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Consumer Staples
• Industry: Consumer Staples Distribution & Retail
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:RADLY
• CIK: N/A
• Web: rdsaude.com.br
• Phone: 551137695678
• Fax: N/A
• Employees: 69,900
• Year Founded: 2011

Profitability

• EPS (Trailing Twelve Months): $0.05
• Trailing P/E Ratio: 66.40
• Forward P/E Ratio: 19.53
• P/E Growth: N/A
• Net Income: $232.27 million
• Net Margins: 2.97%
• Pretax Margin: 3.34%
• Return on Equity: 18.20%
• Return on Assets: 5.32%

Debt

• Debt-to-Equity Ratio: 0.99
• Current Ratio: 1.41
• Quick Ratio: 0.58

Sales & Book Value

• Annual Sales: $7.93 billion
• Price / Sales: 0.55
• Cash Flow: $0.44 per share
• Price / Cash Flow: 7.47
• Book Value: $1.00 per share
• Price / Book: 3.32

Miscellaneous

• Outstanding Shares: 1,315,250,000
• Free Float: N/A
• Market Cap: $4.37 billion
• Optionable: Not Optionable
• Beta: N/A